MoneyWorks4Me

Zim Laboratories - Quaterly Results

09 Nov 2024 Evaluate
The September 2024 quarter revenue stood at Rs. 897.21 millions, up 5.23% as compared to Rs. 852.60 millions during the corresponding quarter last year.Net Profit of the company move down -70.86% to Rs. 12.17  millions from Rs. 41.77 millions  in the same quarter last year.A decline of 97.12 millions was observed in the OP in the quarter ended September 2024 from 103.83 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 897.21 852.60 5.23 1717.25 1522.67 12.78 3654.73 3965.31 -7.83
Other Income 13.22 14.21 -6.97 23.02 20.53 12.13 46.91 64.31 -27.06
PBIDT 97.12 103.83 -6.46 185.70 155.55 19.38 447.94 576.21 -22.26
Interest 28.86 12.17 137.14 57.44 29.51 94.65 69.24 55.75 24.20
PBDT 68.26 91.66 -25.53 128.26 126.04 1.76 378.70 520.46 -27.24
Depreciation 49.73 37.17 33.79 98.89 73.77 34.05 148.29 161.28 -8.05
PBT 18.53 54.49 -65.99 29.37 52.27 -43.81 230.41 359.18 -35.85
TAX 6.36 12.72 -50.00 9.61 11.92 -19.38 62.84 109.09 -42.40
Deferred Tax 4.00 4.53 -11.70 5.15 3.73 38.07 54.55 46.30 17.82
PAT 12.17 41.77 -70.86 19.76 40.35 -51.03 167.57 250.09 -33.00
Equity 487.26 487.26 0.00 487.26 487.26 0.00 487.26 487.26 0.00
PBIDTM(%) 10.82 12.18 -11.11 10.81 10.22 5.86 12.26 14.53 -15.66
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..